Carles X. Raventós

Redefining Clinically Significant Castration Levels in Patients With Prostate Cancer Receiving Continuous Androgen Deprivation Therapy

Juan Moróte, Anna Orsola, Jacques Planas et al. · The Journal of Urology · 2007 · 256 citations

Prevalence of Osteoporosis During Long-Term Androgen Deprivation Therapy in Patients with Prostate Cancer

Juan Moróte, Jacques Morin, Anna Orsola et al. · Urology · 2007 · 182 citations

Bone Disease, Urology, Medicine +5

Initial High-Grade T1 Urothelial Cell Carcinoma: Feasibility and Prognostic Significance of Lamina Propria Invasion Microstaging (T1a/b/c) in BCG-Treated and BCG-Non-Treated Patients

Anna Orsola, Isabel Trias, Carles X. Raventós et al. · European Urology · 2005 · 182 citations

Urological Research, Urology, Genitourinary Cancer +6

Bone Mineral Density Changes in Patients With Prostate Cancer During the First 2 Years of Androgen Suppression

Juan Moróte, Anna Orsola, J.M. Abascal Junquera et al. · The Journal of Urology · 2006 · 93 citations

Comparison of Percent Free Prostate Specific Antigen and Prostate Specific Antigen Density as Methods to Enhance Prostate Specific Antigen Specificity in Early Prostate Cancer Detection in Men With Normal Rectal Examination and Prostate Specific Antigen Between 4.1 and 10 ng./ml.

Juan Moróte, Carles X. Raventós, José A. Lorente et al. · The Journal of Urology · 1997 · 72 citations